Cargando…
Potential of mRNA vaccines to become versatile cancer vaccines
For centuries, therapeutic cancer vaccines have been developed and tried clinically. Way back in the late 19(th )century, the Father of Immunotherapy, William Coley had discovered that bacterial toxins were effective for inoperable sarcomas. In the 1970s, the Bacillus Calmette-Guérin (BCG) vaccine w...
Autor principal: | Tsao, Shiu-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476609/ https://www.ncbi.nlm.nih.gov/pubmed/36160466 http://dx.doi.org/10.5306/wjco.v13.i8.663 |
Ejemplares similares
-
Synergetic role of integrating the departments of cancer registry and clinical research at an academic comprehensive cancer center
por: Bedra, McKenzie, et al.
Publicado: (2017) -
Modified FOLFIRINOX for resected pancreatic cancer: Opportunities and challenges
por: Yang, Feng, et al.
Publicado: (2019) -
Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017) -
Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
por: Aprile, Carlo, et al.
Publicado: (2016) -
Machine learning algorithm to construct cuproptosis- and immune-related prognosis prediction model for colon cancer
por: Huang, Yuan-Yi, et al.
Publicado: (2023)